Recursion Pharmaceuticals Inc (RXRX)
7.86
+0.24
(+3.15%)
USD |
NASDAQ |
Apr 23, 10:07
Recursion Pharmaceuticals Total Assets (Quarterly): 653.70M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 653.70M |
| September 30, 2023 | 630.82M |
| June 30, 2023 | 666.70M |
| March 31, 2023 | 627.37M |
| December 31, 2022 | 701.29M |
| September 30, 2022 | 611.53M |
| June 30, 2022 | 672.52M |
| Date | Value |
|---|---|
| March 31, 2022 | 734.32M |
| December 31, 2021 | 610.34M |
| September 30, 2021 | 658.61M |
| June 30, 2021 | 698.59M |
| March 31, 2021 | 271.94M |
| December 31, 2020 | 298.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
271.94M
Minimum
Mar 2021
734.32M
Maximum
Mar 2022
602.79M
Average
653.70M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 64.01B |
| Palatin Technologies Inc | 13.55M |
| Oragenics Inc | 4.966M |
| Editas Medicine Inc | 499.15M |
| BioXcel Therapeutics Inc | 73.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 190.26M |
| Shareholders Equity (Quarterly) | 463.44M |
| Debt to Equity Ratio | 0.0025 |
| Current Ratio | 4.702 |
| Net Debt Paydown Yield | -0.00% |